Decipher Labs Limited (BOM:524752)
8.59
+0.43 (5.27%)
At close: Feb 12, 2026
Decipher Labs Revenue
Decipher Labs had revenue of 32.28M INR in the quarter ending December 31, 2025, a decrease of -45.96%. This brings the company's revenue in the last twelve months to 148.66M, down -51.10% year-over-year. In the fiscal year ending March 31, 2025, Decipher Labs had annual revenue of 239.29M, down -34.03%.
Revenue (ttm)
148.66M
Revenue Growth
-51.10%
P/S Ratio
0.49
Revenue / Employee
176.11M
Employees
1
Market Cap
86.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 239.29M | -123.46M | -34.03% |
| Mar 31, 2024 | 362.75M | -166.41M | -31.45% |
| Mar 31, 2023 | 529.16M | -124.06M | -18.99% |
| Mar 31, 2022 | 653.22M | 97.60M | 17.57% |
| Mar 31, 2021 | 555.62M | 315.76M | 131.64% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivanza Biosciences | 663.49M |
| Cian Healthcare | 232.80M |
| Beryl Drugs | 176.65M |
| Brawn Biotech | 168.03M |
| Unjha Formulations | 148.12M |
| Norris Medicines | 72.84M |
| Ganga Pharmaceuticals | 26.93M |
| Emmessar Biotech & Nutrition | 20.06M |